Boston Scientific Exceeds Q1 Expectations Amid Market Challenges, Boosts Full-Year Outlook
Boston Scientific Corp reported strong Q1 2025 earnings, exceeding market expectations and prompting an upgrade in its full-year guidance, despite facing external challenges.
2 minutes to read